SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Revance Therapeutics, Inc. – ‘10-K’ for 12/31/23 – ‘XML’

On:  Wednesday, 2/28/24, at 4:33pm ET   ·   For:  12/31/23   ·   Accession #:  1479290-24-38   ·   File #:  1-36297

Previous ‘10-K’:  ‘10-K’ on 2/28/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   39 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/28/24  Revance Therapeutics, Inc.        10-K       12/31/23  110:12M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.67M 
 2: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     48K 
 3: EX-10.32    Material Contract                                   HTML     30K 
 4: EX-21.1     Subsidiaries List                                   HTML     28K 
 5: EX-23.1     Consent of Expert or Counsel                        HTML     28K 
10: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     50K 
                Awarded Compensation                                             
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     33K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     31K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     31K 
16: R1          Cover                                               HTML     95K 
17: R2          Audit Information                                   HTML     34K 
18: R3          Consolidated Balance Sheets                         HTML    150K 
19: R4          Consolidated Balance Sheets (Parenthetical)         HTML     49K 
20: R5          Consolidated Statements of Operations and           HTML    126K 
                Comprehensive Loss                                               
21: R6          Consolidated Statements of Stockholders' Equity     HTML    122K 
                (Deficit)                                                        
22: R7          Consolidated Statements of Cash Flows               HTML    134K 
23: R8          The Company                                         HTML     39K 
24: R9          Summary of Significant Accounting Policies          HTML     91K 
25: R10         Revenue                                             HTML    112K 
26: R11         Restructuring                                       HTML     44K 
27: R12         Cash Equivalents and Short-Term Investments         HTML     69K 
28: R13         Goodwill and Intangible Assets, net                 HTML     98K 
29: R14         Inventories                                         HTML     37K 
30: R15         Accruals and other current liabilities              HTML     44K 
31: R16         Leases                                              HTML     93K 
32: R17         Debt                                                HTML     64K 
33: R18         Stock-based Compensation                            HTML    115K 
34: R19         Stockholders' Equity                                HTML     48K 
35: R20         Fair Value Measurement                              HTML     64K 
36: R21         Income Taxes                                        HTML    101K 
37: R22         Commitments and Contingencies                       HTML     44K 
38: R23         Segment Information                                 HTML     60K 
39: R24         Subsequent Event                                    HTML     31K 
40: R25         Pay vs Performance Disclosure                       HTML     41K 
41: R26         Insider Trading Arrangements                        HTML     35K 
42: R27         Summary of Significant Accounting Policies          HTML    140K 
                (Policies)                                                       
43: R28         Summary of Significant Accounting Policies          HTML     39K 
                (Tables)                                                         
44: R29         Revenue (Tables)                                    HTML    102K 
45: R30         Restructuring (Tables)                              HTML     43K 
46: R31         Cash Equivalents and Short-Term Investments         HTML     70K 
                (Tables)                                                         
47: R32         Goodwill and Intangible Assets, net (Tables)        HTML     99K 
48: R33         Inventories (Tables)                                HTML     38K 
49: R34         Accruals and other current liabilities (Tables)     HTML     43K 
50: R35         Leases (Tables)                                     HTML     87K 
51: R36         Debt (Tables)                                       HTML     50K 
52: R37         Stock-based Compensation (Tables)                   HTML    108K 
53: R38         Stockholders' Equity (Tables)                       HTML     39K 
54: R39         Fair Value Measurement (Tables)                     HTML     62K 
55: R40         Income Taxes (Tables)                               HTML     99K 
56: R41         Segment Information (Tables)                        HTML     54K 
57: R42         The Company (Details)                               HTML     61K 
58: R43         Summary of Significant Accounting Policies -        HTML     69K 
                Narrative (Details)                                              
59: R44         Summary of Significant Accounting Policies -        HTML     65K 
                Schedule of Reclassification (Details)                           
60: R45         Revenue -Revenues Disaggregated by Timing of        HTML     58K 
                Transfer of Goods or Services (Details)                          
61: R46         Revenue - Receivables and Contract Liabilities      HTML     42K 
                (Details)                                                        
62: R47         Revenue - Narrative (Details)                       HTML     64K 
63: R48         Revenue - Contract Liabilities from Contracts       HTML     47K 
                (Details)                                                        
64: R49         Revenue - Changes in Our Contract Liabilities from  HTML     36K 
                Contracts (Details)                                              
65: R50         Restructuring - Narrative (Details)                 HTML     38K 
66: R51         Restructuring - Schedule of Restructuring Charges   HTML     43K 
                (Details)                                                        
67: R52         Restructuring - Schedule of Severance and           HTML     38K 
                Personnel Liabilities (Details)                                  
68: R53         Cash Equivalents and Short-Term Investments         HTML     63K 
                (Details)                                                        
69: R54         Goodwill and Intangible Assets, net - Narrative     HTML     52K 
                (Details)                                                        
70: R55         Goodwill and Intangible Assets, net - Goodwill      HTML     42K 
                (Details)                                                        
71: R56         Goodwill and Intangible Assets, net - Intangible    HTML     65K 
                Assets and the Remaining Useful Lives (Details)                  
72: R57         Goodwill and Intangible Assets, net - Amortization  HTML     47K 
                Expense (Details)                                                
73: R58         Goodwill and Intangible Assets, net - Expected      HTML     43K 
                Amortization Expense for the Unamortized Acquired                
                Intangible Assets (Details)                                      
74: R59         Inventories (Details)                               HTML     38K 
75: R60         Accruals and other current liabilities - Schedule   HTML     45K 
                of Accrued Liabilities (Details)                                 
76: R61         Leases - Narrative (Details)                        HTML     76K 
77: R62         Leases - Operating Lease Costs (Details)            HTML     47K 
78: R63         Leases - Maturities of Lease Liabilities (Details)  HTML     85K 
79: R64         Leases - Remaining Lease terms and Discount Rates   HTML     40K 
                (Details)                                                        
80: R65         Leases - Supplemental Cash Flow Information         HTML     50K 
                (Details)                                                        
81: R66         Debt - Carrying Amount of Liability Component       HTML     55K 
                (Details)                                                        
82: R67         Debt - Interest Expense (Details)                   HTML     40K 
83: R68         Debt - Convertible Senior Notes (Details)           HTML     66K 
84: R69         Debt - Capped Call Transactions (Details)           HTML     49K 
85: R70         Debt - Notes Payable (Details)                      HTML     92K 
86: R71         Stock-based Compensation - Stock Option Plan -      HTML    135K 
                Narrative (Details)                                              
87: R72         Stock-based Compensation - Stock Option Plan -      HTML     70K 
                Summary of Stock Option (Details)                                
88: R73         Stock-based Compensation - Stock Option Plan -      HTML     64K 
                Summary of Restricted Stock Activity (Details)                   
89: R74         Stock-based Compensation - Stock Option Plan -      HTML     53K 
                Fair Value Assumptions (Details)                                 
90: R75         Stock-based Compensation - Stock Option Plan -      HTML     44K 
                Schedule of Stock-based Compensation Expense                     
                (Details)                                                        
91: R76         Stock-based Compensation - Unrecognized             HTML     47K 
                Compensation Cost (Details)                                      
92: R77         Stockholders' Equity (Details)                      HTML     69K 
93: R78         Stockholders? Equity and Stock-Based Compensation   HTML     42K 
                - Schedule of Common Stock Equivalents Excluded                  
                from the Calculation of Earnings per Share                       
                (Details)                                                        
94: R79         Fair Value Measurement - Schedule of Fair Value of  HTML     69K 
                Financial Instruments (Details)                                  
95: R80         Fair Value Measurement - Narrative (Details)        HTML     31K 
96: R81         Income Taxes -Income Taxes Provision (Details)      HTML     40K 
97: R82         Income Taxes - Effective Tax Rate Reconciliation    HTML     55K 
                (Details)                                                        
98: R83         Income Taxes - Deferred Tax Assets and Liabilities  HTML     66K 
                (Details)                                                        
99: R84         Income Taxes - Narrative (Details)                  HTML     53K 
100: R85         Income Taxes - Unrecognized Tax Benefits (Details)  HTML     36K  
101: R86         Commitments and Contingencies - Additional          HTML     54K  
                Information (Details)                                            
102: R87         Segment Information - Schedule of Reconciliation    HTML     43K  
                of Segment Revenue to Consolidated Revenue                       
                (Details)                                                        
103: R88         Segment Information - Schedule of Reconciliation    HTML     43K  
                of Segment Loss from Operations to Consolidated                  
                Loss from Operations (Details)                                   
104: R89         Subsequent Event (Details)                          HTML     37K  
105: R9999       Uncategorized Items - rvnc-20231231.htm             HTML     48K  
107: XML         IDEA XML File -- Filing Summary                      XML    193K  
110: XML         XBRL Instance -- rvnc-20231231_htm                   XML   2.44M  
106: EXCEL       IDEA Workbook of Financial Report Info              XLSX    215K  
12: EX-101.CAL  XBRL Calculations -- rvnc-20231231_cal               XML    322K 
13: EX-101.DEF  XBRL Definitions -- rvnc-20231231_def                XML    863K 
14: EX-101.LAB  XBRL Labels -- rvnc-20231231_lab                     XML   2.50M 
15: EX-101.PRE  XBRL Presentations -- rvnc-20231231_pre              XML   1.48M 
11: EX-101.SCH  XBRL Schema -- rvnc-20231231                         XSD    229K 
108: JSON        XBRL Instance as JSON Data -- MetaLinks              692±  1.01M  
109: ZIP         XBRL Zipped Folder -- 0001479290-24-000038-xbrl      Zip    911K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.24.0.1 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 346 </ContextCount>
<ElementCount> 479 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 115 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 11 </UnitCount>
<MyReports>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 0000001 - Document - Cover </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/Cover </Role>
<ShortName> Cover </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 0000002 - Document - Audit Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/AuditInformation </Role>
<ShortName> Audit Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 0000003 - Statement - Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConsolidatedBalanceSheets </Role>
<ShortName> Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 0000004 - Statement - Consolidated Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> Consolidated Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 0000005 - Statement - Consolidated Statements of Operations and Comprehensive Loss </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss </Role>
<ShortName> Consolidated Statements of Operations and Comprehensive Loss </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 0000006 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConsolidatedStatementsofStockholdersEquityDeficit </Role>
<ShortName> Consolidated Statements of Stockholders' Equity (Deficit) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 0000007 - Statement - Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/ConsolidatedStatementsofCashFlows </Role>
<ShortName> Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 0000008 - Disclosure - The Company </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/TheCompany </Role>
<ShortName> The Company </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 0000009 - Disclosure - Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SummaryofSignificantAccountingPolicies </Role>
<ShortName> Summary of Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 0000010 - Disclosure - Revenue </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/Revenue </Role>
<ShortName> Revenue </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 0000011 - Disclosure - Restructuring </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/Restructuring </Role>
<ShortName> Restructuring </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 0000012 - Disclosure - Cash Equivalents and Short-Term Investments </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CashEquivalentsandShortTermInvestments </Role>
<ShortName> Cash Equivalents and Short-Term Investments </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 0000013 - Disclosure - Goodwill and Intangible Assets, net </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/GoodwillandIntangibleAssetsnet </Role>
<ShortName> Goodwill and Intangible Assets, net </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 0000014 - Disclosure - Inventories </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/Inventories </Role>
<ShortName> Inventories </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 0000015 - Disclosure - Accruals and other current liabilities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/Accrualsandothercurrentliabilities </Role>
<ShortName> Accruals and other current liabilities </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 0000016 - Disclosure - Leases </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/Leases </Role>
<ShortName> Leases </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 0000017 - Disclosure - Debt </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/Debt </Role>
<ShortName> Debt </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 0000018 - Disclosure - Stock-based Compensation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockbasedCompensation </Role>
<ShortName> Stock-based Compensation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 0000019 - Disclosure - Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockholdersEquity </Role>
<ShortName> Stockholders' Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 0000020 - Disclosure - Fair Value Measurement </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/FairValueMeasurement </Role>
<ShortName> Fair Value Measurement </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 0000021 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 21 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 0000022 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CommitmentsandContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 22 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 0000023 - Disclosure - Segment Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SegmentInformation </Role>
<ShortName> Segment Information </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 23 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 0000024 - Disclosure - Subsequent Event </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SubsequentEvent </Role>
<ShortName> Subsequent Event </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 24 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 995410 - Disclosure - Pay vs Performance Disclosure </LongName>
<ReportType> Sheet </ReportType>
<Role> http://xbrl.sec.gov/ecd/role/PvpDisclosure </Role>
<ShortName> Pay vs Performance Disclosure </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 25 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 995445 - Disclosure - Insider Trading Arrangements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements </Role>
<ShortName> Insider Trading Arrangements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 26 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 9954471 - Disclosure - Summary of Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SummaryofSignificantAccountingPoliciesPolicies </Role>
<ShortName> Summary of Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://www.revance.com/role/SummaryofSignificantAccountingPolicies </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 9954472 - Disclosure - Summary of Significant Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SummaryofSignificantAccountingPoliciesTables </Role>
<ShortName> Summary of Significant Accounting Policies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/SummaryofSignificantAccountingPolicies </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 9954473 - Disclosure - Revenue (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/RevenueTables </Role>
<ShortName> Revenue (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/Revenue </ParentRole>
<Position> 29 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 9954474 - Disclosure - Restructuring (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/RestructuringTables </Role>
<ShortName> Restructuring (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/Restructuring </ParentRole>
<Position> 30 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 9954475 - Disclosure - Cash Equivalents and Short-Term Investments (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CashEquivalentsandShortTermInvestmentsTables </Role>
<ShortName> Cash Equivalents and Short-Term Investments (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/CashEquivalentsandShortTermInvestments </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 9954476 - Disclosure - Goodwill and Intangible Assets, net (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/GoodwillandIntangibleAssetsnetTables </Role>
<ShortName> Goodwill and Intangible Assets, net (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/GoodwillandIntangibleAssetsnet </ParentRole>
<Position> 32 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 9954477 - Disclosure - Inventories (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/InventoriesTables </Role>
<ShortName> Inventories (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/Inventories </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 9954478 - Disclosure - Accruals and other current liabilities (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/AccrualsandothercurrentliabilitiesTables </Role>
<ShortName> Accruals and other current liabilities (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/Accrualsandothercurrentliabilities </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 9954479 - Disclosure - Leases (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/LeasesTables </Role>
<ShortName> Leases (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/Leases </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 9954480 - Disclosure - Debt (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/DebtTables </Role>
<ShortName> Debt (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/Debt </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 9954481 - Disclosure - Stock-based Compensation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockbasedCompensationTables </Role>
<ShortName> Stock-based Compensation (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/StockbasedCompensation </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 9954482 - Disclosure - Stockholders' Equity (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockholdersEquityTables </Role>
<ShortName> Stockholders' Equity (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/StockholdersEquity </ParentRole>
<Position> 38 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 9954483 - Disclosure - Fair Value Measurement (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/FairValueMeasurementTables </Role>
<ShortName> Fair Value Measurement (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/FairValueMeasurement </ParentRole>
<Position> 39 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 9954484 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxesTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/IncomeTaxes </ParentRole>
<Position> 40 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 9954485 - Disclosure - Segment Information (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SegmentInformationTables </Role>
<ShortName> Segment Information (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.revance.com/role/SegmentInformation </ParentRole>
<Position> 41 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 9954486 - Disclosure - The Company (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/TheCompanyDetails </Role>
<ShortName> The Company (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.revance.com/role/TheCompany </ParentRole>
<Position> 42 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 9954487 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 43 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 9954488 - Disclosure - Summary of Significant Accounting Policies - Schedule of Reclassification (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SummaryofSignificantAccountingPoliciesScheduleofReclassificationDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Schedule of Reclassification (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 44 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 9954489 - Disclosure - Revenue -Revenues Disaggregated by Timing of Transfer of Goods or Services (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/RevenueRevenuesDisaggregatedbyTimingofTransferofGoodsorServicesDetails </Role>
<ShortName> Revenue -Revenues Disaggregated by Timing of Transfer of Goods or Services (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 45 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 9954490 - Disclosure - Revenue - Receivables and Contract Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/RevenueReceivablesandContractLiabilitiesDetails </Role>
<ShortName> Revenue - Receivables and Contract Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 46 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 9954491 - Disclosure - Revenue - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/RevenueNarrativeDetails </Role>
<ShortName> Revenue - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 47 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 9954492 - Disclosure - Revenue - Contract Liabilities from Contracts (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/RevenueContractLiabilitiesfromContractsDetails </Role>
<ShortName> Revenue - Contract Liabilities from Contracts (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 48 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 9954493 - Disclosure - Revenue - Changes in Our Contract Liabilities from Contracts (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/RevenueChangesinOurContractLiabilitiesfromContractsDetails </Role>
<ShortName> Revenue - Changes in Our Contract Liabilities from Contracts (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 49 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 9954494 - Disclosure - Restructuring - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/RestructuringNarrativeDetails </Role>
<ShortName> Restructuring - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 50 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 9954495 - Disclosure - Restructuring - Schedule of Restructuring Charges (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/RestructuringScheduleofRestructuringChargesDetails </Role>
<ShortName> Restructuring - Schedule of Restructuring Charges (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 51 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 9954496 - Disclosure - Restructuring - Schedule of Severance and Personnel Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/RestructuringScheduleofSeveranceandPersonnelLiabilitiesDetails </Role>
<ShortName> Restructuring - Schedule of Severance and Personnel Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 52 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 9954497 - Disclosure - Cash Equivalents and Short-Term Investments (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CashEquivalentsandShortTermInvestmentsDetails </Role>
<ShortName> Cash Equivalents and Short-Term Investments (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.revance.com/role/CashEquivalentsandShortTermInvestmentsTables </ParentRole>
<Position> 53 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R54.htm </HtmlFileName>
<LongName> 9954498 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails </Role>
<ShortName> Goodwill and Intangible Assets, net - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 54 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R55.htm </HtmlFileName>
<LongName> 9954499 - Disclosure - Goodwill and Intangible Assets, net - Goodwill (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/GoodwillandIntangibleAssetsnetGoodwillDetails </Role>
<ShortName> Goodwill and Intangible Assets, net - Goodwill (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 55 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R56.htm </HtmlFileName>
<LongName> 9954500 - Disclosure - Goodwill and Intangible Assets, net - Intangible Assets and the Remaining Useful Lives (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/GoodwillandIntangibleAssetsnetIntangibleAssetsandtheRemainingUsefulLivesDetails </Role>
<ShortName> Goodwill and Intangible Assets, net - Intangible Assets and the Remaining Useful Lives (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 56 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R57.htm </HtmlFileName>
<LongName> 9954501 - Disclosure - Goodwill and Intangible Assets, net - Amortization Expense (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/GoodwillandIntangibleAssetsnetAmortizationExpenseDetails </Role>
<ShortName> Goodwill and Intangible Assets, net - Amortization Expense (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 57 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R58.htm </HtmlFileName>
<LongName> 9954502 - Disclosure - Goodwill and Intangible Assets, net - Expected Amortization Expense for the Unamortized Acquired Intangible Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/GoodwillandIntangibleAssetsnetExpectedAmortizationExpensefortheUnamortizedAcquiredIntangibleAssetsDetails </Role>
<ShortName> Goodwill and Intangible Assets, net - Expected Amortization Expense for the Unamortized Acquired Intangible Assets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 58 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R59.htm </HtmlFileName>
<LongName> 9954503 - Disclosure - Inventories (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/InventoriesDetails </Role>
<ShortName> Inventories (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.revance.com/role/InventoriesTables </ParentRole>
<Position> 59 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R60.htm </HtmlFileName>
<LongName> 9954504 - Disclosure - Accruals and other current liabilities - Schedule of Accrued Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/AccrualsandothercurrentliabilitiesScheduleofAccruedLiabilitiesDetails </Role>
<ShortName> Accruals and other current liabilities - Schedule of Accrued Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 60 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R61.htm </HtmlFileName>
<LongName> 9954505 - Disclosure - Leases - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/LeasesNarrativeDetails </Role>
<ShortName> Leases - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 61 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R62.htm </HtmlFileName>
<LongName> 9954506 - Disclosure - Leases - Operating Lease Costs (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/LeasesOperatingLeaseCostsDetails </Role>
<ShortName> Leases - Operating Lease Costs (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 62 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R63.htm </HtmlFileName>
<LongName> 9954507 - Disclosure - Leases - Maturities of Lease Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails </Role>
<ShortName> Leases - Maturities of Lease Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 63 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R64.htm </HtmlFileName>
<LongName> 9954508 - Disclosure - Leases - Remaining Lease terms and Discount Rates (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/LeasesRemainingLeasetermsandDiscountRatesDetails </Role>
<ShortName> Leases - Remaining Lease terms and Discount Rates (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 64 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R65.htm </HtmlFileName>
<LongName> 9954509 - Disclosure - Leases - Supplemental Cash Flow Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/LeasesSupplementalCashFlowInformationDetails </Role>
<ShortName> Leases - Supplemental Cash Flow Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 65 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R66.htm </HtmlFileName>
<LongName> 9954510 - Disclosure - Debt - Carrying Amount of Liability Component (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/DebtCarryingAmountofLiabilityComponentDetails </Role>
<ShortName> Debt - Carrying Amount of Liability Component (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 66 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R67.htm </HtmlFileName>
<LongName> 9954511 - Disclosure - Debt - Interest Expense (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/DebtInterestExpenseDetails </Role>
<ShortName> Debt - Interest Expense (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 67 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R68.htm </HtmlFileName>
<LongName> 9954512 - Disclosure - Debt - Convertible Senior Notes (Details) </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.revance.com/role/DebtConvertibleSeniorNotesDetails </Role>
<ShortName> Debt - Convertible Senior Notes (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 68 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R69.htm </HtmlFileName>
<LongName> 9954513 - Disclosure - Debt - Capped Call Transactions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/DebtCappedCallTransactionsDetails </Role>
<ShortName> Debt - Capped Call Transactions (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 69 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R70.htm </HtmlFileName>
<LongName> 9954514 - Disclosure - Debt - Notes Payable (Details) </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.revance.com/role/DebtNotesPayableDetails </Role>
<ShortName> Debt - Notes Payable (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 70 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R71.htm </HtmlFileName>
<LongName> 9954515 - Disclosure - Stock-based Compensation - Stock Option Plan - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockbasedCompensationStockOptionPlanNarrativeDetails </Role>
<ShortName> Stock-based Compensation - Stock Option Plan - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 71 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R72.htm </HtmlFileName>
<LongName> 9954516 - Disclosure - Stock-based Compensation - Stock Option Plan - Summary of Stock Option (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockbasedCompensationStockOptionPlanSummaryofStockOptionDetails </Role>
<ShortName> Stock-based Compensation - Stock Option Plan - Summary of Stock Option (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 72 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R73.htm </HtmlFileName>
<LongName> 9954517 - Disclosure - Stock-based Compensation - Stock Option Plan - Summary of Restricted Stock Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockbasedCompensationStockOptionPlanSummaryofRestrictedStockActivityDetails </Role>
<ShortName> Stock-based Compensation - Stock Option Plan - Summary of Restricted Stock Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 73 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R74.htm </HtmlFileName>
<LongName> 9954518 - Disclosure - Stock-based Compensation - Stock Option Plan - Fair Value Assumptions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockbasedCompensationStockOptionPlanFairValueAssumptionsDetails </Role>
<ShortName> Stock-based Compensation - Stock Option Plan - Fair Value Assumptions (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 74 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R75.htm </HtmlFileName>
<LongName> 9954519 - Disclosure - Stock-based Compensation - Stock Option Plan - Schedule of Stock-based Compensation Expense (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockbasedCompensationStockOptionPlanScheduleofStockbasedCompensationExpenseDetails </Role>
<ShortName> Stock-based Compensation - Stock Option Plan - Schedule of Stock-based Compensation Expense (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 75 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R76.htm </HtmlFileName>
<LongName> 9954520 - Disclosure - Stock-based Compensation - Unrecognized Compensation Cost (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockbasedCompensationUnrecognizedCompensationCostDetails </Role>
<ShortName> Stock-based Compensation - Unrecognized Compensation Cost (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 76 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R77.htm </HtmlFileName>
<LongName> 9954521 - Disclosure - Stockholders' Equity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockholdersEquityDetails </Role>
<ShortName> Stockholders' Equity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.revance.com/role/StockholdersEquityTables </ParentRole>
<Position> 77 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R78.htm </HtmlFileName>
<LongName> 9954522 - Disclosure - Stockholders??? Equity and Stock-Based Compensation - Schedule of Common Stock Equivalents Excluded from the Calculation of Earnings per Share (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/StockholdersEquityandStockBasedCompensationScheduleofCommonStockEquivalentsExcludedfromtheCalculationofEarningsperShareDetails </Role>
<ShortName> Stockholders??? Equity and Stock-Based Compensation - Schedule of Common Stock Equivalents Excluded from the Calculation of Earnings per Share (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 78 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R79.htm </HtmlFileName>
<LongName> 9954523 - Disclosure - Fair Value Measurement - Schedule of Fair Value of Financial Instruments (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/FairValueMeasurementScheduleofFairValueofFinancialInstrumentsDetails </Role>
<ShortName> Fair Value Measurement - Schedule of Fair Value of Financial Instruments (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 79 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R80.htm </HtmlFileName>
<LongName> 9954524 - Disclosure - Fair Value Measurement - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/FairValueMeasurementNarrativeDetails </Role>
<ShortName> Fair Value Measurement - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 80 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R81.htm </HtmlFileName>
<LongName> 9954525 - Disclosure - Income Taxes -Income Taxes Provision (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxesIncomeTaxesProvisionDetails </Role>
<ShortName> Income Taxes -Income Taxes Provision (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 81 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R82.htm </HtmlFileName>
<LongName> 9954526 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails </Role>
<ShortName> Income Taxes - Effective Tax Rate Reconciliation (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 82 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R83.htm </HtmlFileName>
<LongName> 9954527 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails </Role>
<ShortName> Income Taxes - Deferred Tax Assets and Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 83 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R84.htm </HtmlFileName>
<LongName> 9954528 - Disclosure - Income Taxes - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxesNarrativeDetails </Role>
<ShortName> Income Taxes - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 84 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R85.htm </HtmlFileName>
<LongName> 9954529 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails </Role>
<ShortName> Income Taxes - Unrecognized Tax Benefits (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 85 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R86.htm </HtmlFileName>
<LongName> 9954530 - Disclosure - Commitments and Contingencies - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/CommitmentsandContingenciesAdditionalInformationDetails </Role>
<ShortName> Commitments and Contingencies - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 86 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R87.htm </HtmlFileName>
<LongName> 9954531 - Disclosure - Segment Information - Schedule of Reconciliation of Segment Revenue to Consolidated Revenue (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SegmentInformationScheduleofReconciliationofSegmentRevenuetoConsolidatedRevenueDetails </Role>
<ShortName> Segment Information - Schedule of Reconciliation of Segment Revenue to Consolidated Revenue (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 87 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R88.htm </HtmlFileName>
<LongName> 9954532 - Disclosure - Segment Information - Schedule of Reconciliation of Segment Loss from Operations to Consolidated Loss from Operations (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SegmentInformationScheduleofReconciliationofSegmentLossfromOperationstoConsolidatedLossfromOperationsDetails </Role>
<ShortName> Segment Information - Schedule of Reconciliation of Segment Loss from Operations to Consolidated Loss from Operations (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 88 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R89.htm </HtmlFileName>
<LongName> 9954533 - Disclosure - Subsequent Event (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.revance.com/role/SubsequentEventDetails </Role>
<ShortName> Subsequent Event (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.revance.com/role/SubsequentEvent </ParentRole>
<Position> 89 </Position>
</Report>
<Report instance="rvnc-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9999.htm </HtmlFileName>
<LongName> Uncategorized Items - rvnc-20231231.htm </LongName>
<ReportType> Sheet </ReportType>
<Role> http://xbrl.sec.gov/role/uncategorizedFacts </Role>
<ShortName> Uncategorized Items - rvnc-20231231.htm </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 90 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="rvnc-20231231.htm"> rvnc-20231231.htm </File>
<File> rvnc-20231231.xsd </File>
<File> rvnc-20231231_cal.xml </File>
<File> rvnc-20231231_def.xml </File>
<File> rvnc-20231231_lab.xml </File>
<File> rvnc-20231231_pre.xml </File>
</InputFiles>
<SupplementalFiles>
<File> rvnc-20231231_g1.jpg </File>
</SupplementalFiles>
<BaseTaxonomies>
<BaseTaxonomy items="1098"> http://fasb.org/us-gaap/2023 </BaseTaxonomy>
<BaseTaxonomy items="38"> http://xbrl.sec.gov/dei/2023 </BaseTaxonomy>
<BaseTaxonomy items="4"> http://xbrl.sec.gov/ecd/2023 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/21/24  Revance Therapeutics, Inc.        DEF 14A     5/01/24   11:13M
 3/05/24  Revance Therapeutics, Inc.        424B5                  2:551K                                   Donnelley … Solutions/FA
 3/04/24  Revance Therapeutics, Inc.        424B5                  1:535K                                   Donnelley … Solutions/FA
 2/29/24  Revance Therapeutics, Inc.        S-8         2/29/24    4:123K

35 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Revance Therapeutics, Inc.        8-K:1,2,5,9 2/23/24   13:618K
 2/13/24  Revance Therapeutics, Inc.        8-K:5,9     2/07/24   11:376K
11/14/23  Revance Therapeutics, Inc.        S-3ASR     11/14/23    7:846K                                   Donnelley … Solutions/FA
11/08/23  Revance Therapeutics, Inc.        10-Q        9/30/23   84:62M
 5/09/23  Revance Therapeutics, Inc.        10-Q        3/31/23   78:7.7M
 2/28/23  Revance Therapeutics, Inc.        10-K       12/31/22  109:14M
11/08/22  Revance Therapeutics, Inc.        10-Q        9/30/22   78:9.1M
 5/10/22  Revance Therapeutics, Inc.        10-Q        3/31/22   82:9M                                     Donnelley … Solutions/FA
 2/28/22  Revance Therapeutics, Inc.        S-8         2/28/22    5:197K
 2/28/22  Revance Therapeutics, Inc.        10-K       12/31/21  106:12M
12/22/21  Revance Therapeutics, Inc.        8-K:5,9    12/17/21   11:385K
11/09/21  Revance Therapeutics, Inc.        10-Q        9/30/21   81:8.4M
 8/05/21  Revance Therapeutics, Inc.        10-Q        6/30/21   79:8.5M
 5/10/21  Revance Therapeutics, Inc.        10-Q        3/31/21   76:6.7M
 5/07/21  Revance Therapeutics, Inc.        8-K:5,9     5/05/21   13:192K
 2/25/21  Revance Therapeutics, Inc.        10-K       12/31/20  109:12M
11/27/20  Revance Therapeutics, Inc.        S-3ASR     11/27/20    7:1.1M                                   Donnelley … Solutions/FA
11/20/20  Revance Therapeutics, Inc.        8-K:1,2,9  11/17/20   13:854K
11/09/20  Revance Therapeutics, Inc.        10-Q        9/30/20   83:8.3M
 8/06/20  Revance Therapeutics, Inc.        10-Q        6/30/20   64:7.2M
 7/24/20  Revance Therapeutics, Inc.        S-8         7/24/20    4:169K                                   Donnelley … Solutions/FA
 6/10/20  Revance Therapeutics, Inc.        S-4                   94:11M                                    Donnelley … Solutions/FA
 2/26/20  Revance Therapeutics, Inc.        10-K       12/31/19   85:11M
 2/14/20  Revance Therapeutics, Inc.        8-K:1,2,3,8 2/11/20   14:1.4M                                   Donnelley … Solutions/FA
11/04/19  Revance Therapeutics, Inc.        10-Q        9/30/19   60:5.7M
 2/28/19  Revance Therapeutics, Inc.        10-K       12/31/18   86:11M
 5/11/18  Revance Therapeutics, Inc.        8-K:1,5,9   5/10/18    2:261K
 5/09/18  Revance Therapeutics, Inc.        10-Q        3/31/18   54:4.5M
 5/09/17  Revance Therapeutics, Inc.        10-Q        3/31/17   63:4.4M
11/10/15  Revance Therapeutics, Inc.        10-Q        9/30/15   66:5.6M
 3/04/14  Revance Therapeutics, Inc.        8-K:1,9     2/26/14    2:52K                                    Donnelley … Solutions/FA
 2/11/14  Revance Therapeutics, Inc.        8-K:5,9     2/11/14    2:49K                                    Donnelley … Solutions/FA
 2/03/14  Revance Therapeutics, Inc.        S-1/A                  5:4.8M                                   Donnelley … Solutions/FA
 1/27/14  Revance Therapeutics, Inc.        S-1/A¶                22:5.2M                                   Donnelley … Solutions/FA
12/31/13  Revance Therapeutics, Inc.        S-1¶                  30:11M                                    Donnelley … Solutions/FA
↑Top
Filing Submission 0001479290-24-000038   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 14, 8:45:04.4pm ET